Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hennepin Healthcare Research Institute
With
Aventis Pharmaceuticals
Venous thromboembolic (VTE) prophylaxis in trauma patients is a critical clinical problem. Patients with traumatic brain injury usually have effective VTE prophylaxis withheld secondary to concerns of exacerbating intracranial hemorrhage. This study examines the safety and efficacy of early administration (within 24 hrs of admission) of low molecular weight heparin to this patient population with very high VTE risk.
